Santonocito, D.; Raciti, G.; Campisi, A.; Sposito, G.; Panico, A.; Siciliano, E.A.; Sarpietro, M.G.; Damiani, E.; Puglia, C.
Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials 2023, 13, 3088.
https://doi.org/10.3390/nano13243088
AMA Style
Santonocito D, Raciti G, Campisi A, Sposito G, Panico A, Siciliano EA, Sarpietro MG, Damiani E, Puglia C.
Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials. 2023; 13(24):3088.
https://doi.org/10.3390/nano13243088
Chicago/Turabian Style
Santonocito, Debora, Giuseppina Raciti, Agata Campisi, Giovanni Sposito, Annamaria Panico, Edy Angela Siciliano, Maria Grazia Sarpietro, Elisabetta Damiani, and Carmelo Puglia.
2023. "Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391" Nanomaterials 13, no. 24: 3088.
https://doi.org/10.3390/nano13243088
APA Style
Santonocito, D., Raciti, G., Campisi, A., Sposito, G., Panico, A., Siciliano, E. A., Sarpietro, M. G., Damiani, E., & Puglia, C.
(2023). Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. Nanomaterials, 13(24), 3088.
https://doi.org/10.3390/nano13243088
